Zoltán Kis
Zoltán Kis has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Bernadett Pályi
Department of National Biosafety Laboratory, National Center for Public Health and Pharmacy, 1097 Budapest, Hungary
3 shared publications - Judit Henczkó
Department of National Biosafety Laboratory, National Center for Public Health and Pharmacy, 1097 Budapest, Hungary
3 shared publications Bereniké Novák
National Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary
2 shared publicationsBernadett Pályi
National Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary
2 shared publicationsNóra Deézsi-Magyar
National Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary
2 shared publications- Nóra Deézsi-Magyar
Department of National Biosafety Laboratory, National Center for Public Health and Pharmacy, H-1097 Budapest, Hungary
2 shared publications
Latest Publications
- Open Access
Laboratory-Acquired Brucella abortus Infection Mimicking Autoimmune Disease: A Case Report with Genomic Confirmation
Background: Brucellosis is a globally distributed zoonotic disease characterized by highly variable clinical manifestations that may mimic systemic autoimmune and inflammatory disorders. In Europe, where the incidence of brucellosis is relatively low, limited clinical awareness may contribute to delayed diagnosis and inappropriate management. In addition to zoonotic transmission, Brucella species are a well-recognized cause of laboratory-acquired infections (LAIs) among microbiology laboratory personnel. Methods: We report a case of laboratory-acquired Brucella abortus infection in a young woman presenting with undulant fever, arthralgia, systemic inflammation, elevated ferritin levels, and antinuclear antibody (ANA) positivity. Microbiological confirmation was achieved through serological testing (ELISA), repeat blood cultures, species-specific quantitative PCR, and whole-genome sequencing (WGS) followed by core genome multilocus sequence typing (cgMLST). Results: Initial laboratory evaluation revealed elevated C-reactive protein, mildly increased ferritin levels (146 ng/mL), abnormal liver enzyme levels, and rising ANA titers (from 1:160 to 1:320), raising suspicion of a systemic autoimmune disorder and prompting consideration of corticosteroid therapy. Although the initial blood culture was negative, subsequent molecular diagnostics and repeat cultures confirmed B. abortus infection. Epidemiological investigation suggested a possible occupational exposure in a diagnostic microbiology laboratory, consistent with a laboratory-acquired infection. Genomic analysis classified the isolate as sequence type 1 (ST1) and demonstrated zero allelic differences compared with the ST1 reference strain. Targeted antimicrobial therapy resulted in complete clinical recovery, supporting an infection-triggered immune response rather than primary autoimmunity. Conclusions: Acute brucellosis should be considered in the differential diagnosis of febrile syndromes accompanied by autoimmune-like laboratory abnormalities, even in low-incidence regions. This case highlights the diagnostic challenges posed by laboratory-acquired brucellosis and underscores the importance of early microbiological investigation and strict biosafety awareness in laboratory settings.
Open AccessLaboratory-Acquired Brucella abortus Infection Mimicking Autoimmune Disease: A Case Report with Genomic Confirmation
Background: Brucellosis is a globally distributed zoonotic disease characterized by highly variable clinical manifestations that may mimic systemic autoimmune and inflammatory disorders. In Europe, where the incidence of brucellosis is relatively low, limited clinical awareness may contribute to delayed diagnosis and inappropriate management. In addition to zoonotic transmission, Brucella species are a well-recognized cause of laboratory-acquired infections (LAIs) among microbiology laboratory personnel. Methods: We report a case of laboratory-acquired Brucella abortus infection in a young woman presenting with undulant fever, arthralgia, systemic inflammation, elevated ferritin levels, and antinuclear antibody (ANA) positivity. Microbiological confirmation was achieved through serological testing (ELISA), repeat blood cultures, species-specific quantitative PCR, and whole-genome sequencing (WGS) followed by core genome multilocus sequence typing (cgMLST). Results: Initial laboratory evaluation revealed elevated C-reactive protein, mildly increased ferritin levels (146 ng/mL), abnormal liver enzyme levels, and rising ANA titers (from 1:160 to 1:320), raising suspicion of a systemic autoimmune disorder and prompting consideration of corticosteroid therapy. Although the initial blood culture was negative, subsequent molecular diagnostics and repeat cultures confirmed B. abortus infection. Epidemiological investigation suggested a possible occupational exposure in a diagnostic microbiology laboratory, consistent with a laboratory-acquired infection. Genomic analysis classified the isolate as sequence type 1 (ST1) and demonstrated zero allelic differences compared with the ST1 reference strain. Targeted antimicrobial therapy resulted in complete clinical recovery, supporting an infection-triggered immune response rather than primary autoimmunity. Conclusions: Acute brucellosis should be considered in the differential diagnosis of febrile syndromes accompanied by autoimmune-like laboratory abnormalities, even in low-incidence regions. This case highlights the diagnostic challenges posed by laboratory-acquired brucellosis and underscores the importance of early microbiological investigation and strict biosafety awareness in laboratory settings.
- Open Access
- 9 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Genomic characterization of non-O1, non-O139 Vibrio cholerae causing rare clinical manifestation
Background: Non-O1, non-O139 Vibrio cholerae is an uncommon cause of pneumonia, particularly following freshwater exposure. Non-O1, non-O139 Vibrio cholerae was identified from bronchoalveolar lavage through culture and quantitative polymerase chain reaction (qPCR) in Hungary. During an epidemiological investigation, the source of infection was traced to a designated bathing site at a lake in Central Hungary, where non-O1,non-O139 Vibrio cholerae was isolated from surface water. Methods: We conducted whole-genome sequencing and comparative genomic analysis on a clinical isolate ( N = 1) and three phenotypically distinct environmental isolates ( N = 3). In addition, we reviewed the available literature on pulmonary infections associated with Vibrio cholerae . Results: Core genome multilocus sequence typing (cgMLST) revealed that the clinical and environmental isolates clustered together with zero allelic differences. Multilocus sequence typing (MLST) identified a new sequence type (ST1605), representing a novel combination of known allele variants. In silico analysis of antibiotic resistance genes identified the presence of bla CARB-7. Both the clinical and environmental isolates exhibited identical virulence gene profiles, reinforcing the hypothesis that the infection was acquired from a local water source. Conclusions: This study represents the first investigation of a primary pulmonary Vibrio cholerae infection reported in Europe following a near-drowning event. While Vibrio vulnificus and Vibrio metschnikovii have been implicated in similar pneumonia cases, the precise virulence mechanisms of these species remain poorly understood. Although non-O1, non-O139 Vibrio cholerae infections associated with recreational water exposure are rare in Hungary (1–2 cases per year), this study underscores the importance of ongoing surveillance for the detection of potential outbreaks and to inform public health responses.
- 9 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessGenomic characterization of non-O1, non-O139 Vibrio cholerae causing rare clinical manifestation
Background: Non-O1, non-O139 Vibrio cholerae is an uncommon cause of pneumonia, particularly following freshwater exposure. Non-O1, non-O139 Vibrio cholerae was identified from bronchoalveolar lavage through culture and quantitative polymerase chain reaction (qPCR) in Hungary. During an epidemiological investigation, the source of infection was traced to a designated bathing site at a lake in Central Hungary, where non-O1,non-O139 Vibrio cholerae was isolated from surface water. Methods: We conducted whole-genome sequencing and comparative genomic analysis on a clinical isolate ( N = 1) and three phenotypically distinct environmental isolates ( N = 3). In addition, we reviewed the available literature on pulmonary infections associated with Vibrio cholerae . Results: Core genome multilocus sequence typing (cgMLST) revealed that the clinical and environmental isolates clustered together with zero allelic differences. Multilocus sequence typing (MLST) identified a new sequence type (ST1605), representing a novel combination of known allele variants. In silico analysis of antibiotic resistance genes identified the presence of bla CARB-7. Both the clinical and environmental isolates exhibited identical virulence gene profiles, reinforcing the hypothesis that the infection was acquired from a local water source. Conclusions: This study represents the first investigation of a primary pulmonary Vibrio cholerae infection reported in Europe following a near-drowning event. While Vibrio vulnificus and Vibrio metschnikovii have been implicated in similar pneumonia cases, the precise virulence mechanisms of these species remain poorly understood. Although non-O1, non-O139 Vibrio cholerae infections associated with recreational water exposure are rare in Hungary (1–2 cases per year), this study underscores the importance of ongoing surveillance for the detection of potential outbreaks and to inform public health responses.
- Open Access
- 7 November 2025
- Published by Springer Nature in Archives of Virology
- Vol. 170 (12) , 1-14
Phenotypic and genetic changes of Crimean-Congo hemorrhagic fever virus during serial passage in susceptible cell lines
Background Single-stranded RNA viruses such as the Crimean-Congo hemorrhagic fever virus (CCHFV) exhibit a high degree of genetic diversity that can result in the emergence of new viral quasispecies. The aim of this study was to examine the kinetics of CCHFV replication and to identify genetic variations resulting from serial passage in susceptible cell lines that could potentially affect the infectivity and fitness of laboratory virus strains. As efficacy studies of candidate therapeutics and vaccines rely on well-characterized virus stocks, mutations emerging due to virus propagation might result in inaccurate test results. Methods Viral growth kinetics were examined in four cell lines (Vero E6, Vero, SW13, and BHK-21), using different multiplicity-of-infection values. After 10 rounds of serial passaging and cross-passaging, whole-genome sequencing and bioinformatic analysis were performed to map growth-adaptive signature mutations. Results All four cell lines were found to be susceptible to CCHFV infection, and permissivity increased during serial passaging in Vero and BHK-21 cells. Mutations emerged in a cell-line-specific manner, and the particular cell line used for virus propagation had a significant effect on the mutation frequency, especially in the L segment. Conclusions By mapping mutations that occurred during serial passage, we were able to observe viral evolution in a controlled laboratory setting, as well as the accompanying phenotypic changes. Our results provide information about how CCHFV adapts to commonly used cell lines that might be applied for the development of diagnostic tests, antiviral drugs, and vaccines.
- 7 November 2025
- Published by Springer Nature in Archives of Virology
- Vol. 170 (12) , 1-14
Open AccessPhenotypic and genetic changes of Crimean-Congo hemorrhagic fever virus during serial passage in susceptible cell lines
Background Single-stranded RNA viruses such as the Crimean-Congo hemorrhagic fever virus (CCHFV) exhibit a high degree of genetic diversity that can result in the emergence of new viral quasispecies. The aim of this study was to examine the kinetics of CCHFV replication and to identify genetic variations resulting from serial passage in susceptible cell lines that could potentially affect the infectivity and fitness of laboratory virus strains. As efficacy studies of candidate therapeutics and vaccines rely on well-characterized virus stocks, mutations emerging due to virus propagation might result in inaccurate test results. Methods Viral growth kinetics were examined in four cell lines (Vero E6, Vero, SW13, and BHK-21), using different multiplicity-of-infection values. After 10 rounds of serial passaging and cross-passaging, whole-genome sequencing and bioinformatic analysis were performed to map growth-adaptive signature mutations. Results All four cell lines were found to be susceptible to CCHFV infection, and permissivity increased during serial passaging in Vero and BHK-21 cells. Mutations emerged in a cell-line-specific manner, and the particular cell line used for virus propagation had a significant effect on the mutation frequency, especially in the L segment. Conclusions By mapping mutations that occurred during serial passage, we were able to observe viral evolution in a controlled laboratory setting, as well as the accompanying phenotypic changes. Our results provide information about how CCHFV adapts to commonly used cell lines that might be applied for the development of diagnostic tests, antiviral drugs, and vaccines.
- Open Access
Whole Genome Sequencing and Comparative Genomics of the Emerging Pathogen Burkholderia pseudomallei Isolated from Two Travel-Related Infections in Hungary
Background: Burkholderia pseudomallei, the causative agent of melioidosis, is a neglected tropical pathogen that has been increasingly encountered in Europe through travel-related infections. Clinical manifestations range from localized abscesses to life-threatening sepsis, posing diagnostic challenges in non-endemic regions. Methods: We report two travel-associated melioidosis cases confirmed in Hungary between 2008 and 2024. Whole-genome sequencing (WGS), multilocus sequence typing (MLST), and core-genome MLST (cgMLST) were performed for molecular characterization. In parallel, a systematic review of travel-related melioidosis cases reported in Europe (1980–2025) was conducted according to PRISMA 2020 guidelines. Data were retrieved from PubMed, Scopus, Google Scholar, and the PubMLST database. Results: In silico MLST identified two distinct sequence types (STs): a novel ST1643, and ST1051, previously reported in Asia and Australia. Both isolates clustered within the Asian clade, confirming an imported origin. Virulence profiling revealed major determinants, including the Yersinia-like fimbriae (YLF) cluster, fhaB3, and ITS type C. The ST1643 isolate carried the bimABm variant and multiple resistance genes (blaOXA-57, blaPenI, and amrAB efflux system), while ST1051 harbored blaOXA-59. The literature review identified 82 studies encompassing 195 European cases, most originating from Southeast Asia, with pneumonia, followed by septic form and abscess as the predominant presentation. We found only eight neuromelioidosis cases in Europe. Conclusions: This study represents the first report of neuromelioidosis in Hungary, and the first global description of ST1643. Combined genomic and epidemiological data highlight the need for improved clinical awareness, genomic surveillance, and diagnostic preparedness in non-endemic regions, as global travel and climate change expand the distribution of melioidosis.
Open AccessWhole Genome Sequencing and Comparative Genomics of the Emerging Pathogen Burkholderia pseudomallei Isolated from Two Travel-Related Infections in Hungary
Background: Burkholderia pseudomallei, the causative agent of melioidosis, is a neglected tropical pathogen that has been increasingly encountered in Europe through travel-related infections. Clinical manifestations range from localized abscesses to life-threatening sepsis, posing diagnostic challenges in non-endemic regions. Methods: We report two travel-associated melioidosis cases confirmed in Hungary between 2008 and 2024. Whole-genome sequencing (WGS), multilocus sequence typing (MLST), and core-genome MLST (cgMLST) were performed for molecular characterization. In parallel, a systematic review of travel-related melioidosis cases reported in Europe (1980–2025) was conducted according to PRISMA 2020 guidelines. Data were retrieved from PubMed, Scopus, Google Scholar, and the PubMLST database. Results: In silico MLST identified two distinct sequence types (STs): a novel ST1643, and ST1051, previously reported in Asia and Australia. Both isolates clustered within the Asian clade, confirming an imported origin. Virulence profiling revealed major determinants, including the Yersinia-like fimbriae (YLF) cluster, fhaB3, and ITS type C. The ST1643 isolate carried the bimABm variant and multiple resistance genes (blaOXA-57, blaPenI, and amrAB efflux system), while ST1051 harbored blaOXA-59. The literature review identified 82 studies encompassing 195 European cases, most originating from Southeast Asia, with pneumonia, followed by septic form and abscess as the predominant presentation. We found only eight neuromelioidosis cases in Europe. Conclusions: This study represents the first report of neuromelioidosis in Hungary, and the first global description of ST1643. Combined genomic and epidemiological data highlight the need for improved clinical awareness, genomic surveillance, and diagnostic preparedness in non-endemic regions, as global travel and climate change expand the distribution of melioidosis.
- Open Access
- 27 September 2024
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 43 (12) , 2341-2350
First whole genome sequencing and analysis of human parechovirus type 3 causing a healthcare-associated outbreak among neonates in Hungary
Purpose: In November 2023, the National Reference Laboratory for Enteroviruses (Budapest, Hungary) received stool, pharyngeal swab and cerebrospinal fluid samples from five newborns suspected of having human parechovirus (PEV-A) infection. The neonates were born in the same hospital and presented with fever and sepsis-like symptoms at 8–9 days of age, and three of them showed symptoms consistent with central nervous system involvement. PEV-A positivity was confirmed by quantitative reverse transcription polymerase chain reaction. Methods: To determine the PEV-A genotype responsible for the infections, fecal samples of four neonates were subjected to metagenomic sequencing. For further analyses, amplicon-based whole genome sequencing was performed directly from the clinical samples. Results: On the basis of whole genome analysis, sequences were allocated to PEV-A genotype 3 (PEV-A3) and consensus sequences were identical. Two ambiguities were identified in the viral protein 1 (VP1) region of all sequences at a frequency of 17.7–53.7%, indicating the simultaneous presence of at least two quasispecies in the clinical samples. The phylogenetic analysis and similarity plotting showed that all sequences clustered without any topological inconsistencies between the P1 capsid and P2, P3 non-capsid regions, suggesting that recombination events during evolution were unlikely. Conclusion: Our findings suggest that the apparent cluster of cases were microbiologically related, and the results may also inform future investigations on the evolution and pathogenicity of PEV-A3 infections.
- 27 September 2024
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 43 (12) , 2341-2350
Open AccessFirst whole genome sequencing and analysis of human parechovirus type 3 causing a healthcare-associated outbreak among neonates in Hungary
Purpose: In November 2023, the National Reference Laboratory for Enteroviruses (Budapest, Hungary) received stool, pharyngeal swab and cerebrospinal fluid samples from five newborns suspected of having human parechovirus (PEV-A) infection. The neonates were born in the same hospital and presented with fever and sepsis-like symptoms at 8–9 days of age, and three of them showed symptoms consistent with central nervous system involvement. PEV-A positivity was confirmed by quantitative reverse transcription polymerase chain reaction. Methods: To determine the PEV-A genotype responsible for the infections, fecal samples of four neonates were subjected to metagenomic sequencing. For further analyses, amplicon-based whole genome sequencing was performed directly from the clinical samples. Results: On the basis of whole genome analysis, sequences were allocated to PEV-A genotype 3 (PEV-A3) and consensus sequences were identical. Two ambiguities were identified in the viral protein 1 (VP1) region of all sequences at a frequency of 17.7–53.7%, indicating the simultaneous presence of at least two quasispecies in the clinical samples. The phylogenetic analysis and similarity plotting showed that all sequences clustered without any topological inconsistencies between the P1 capsid and P2, P3 non-capsid regions, suggesting that recombination events during evolution were unlikely. Conclusion: Our findings suggest that the apparent cluster of cases were microbiologically related, and the results may also inform future investigations on the evolution and pathogenicity of PEV-A3 infections.
- Open Access
First Broad-Range Serological Survey of Crimean–Congo Hemorrhagic Fever among Hungarian Livestock
(1) Background: Crimean–Congo hemorrhagic fever (CCHF) is an emerging tick-borne disease endemic in Africa, Asia, the Middle East, and the Balkan and Mediterranean regions of Europe. Although no human CCHF cases have been reported, based on vector presence, serological evidence among small vertebrates, and the general human population, Hungary lies within high evidence consensus for potential CCHF introduction and future human infection. Thus, the aim of our pilot serosurvey was to assess CCHF seropositivity among cattle and sheep as indicator animals for virus circulation in the country. (2) Methods: In total, 1905 serum samples taken from free-range cattle and sheep in 2017 were tested for the presence of anti-CCHF virus IgG antibodies using commercial ELISA and commercial and in-house immunofluorescent assays. (3) Results: We found a total of eleven reactive samples (0.58%) from five administrative districts of Hungary comprising 8 cattle and 3 sheep. The most affected regions were the south–central and northwestern parts of the country. (4) Conclusions: Based on these results, more extended surveillance is advised, especially in the affected areas, and there should be greater awareness among clinicians and other high-risk populations of the emerging threat of CCHF in Hungary and Central Europe.
Open AccessFirst Broad-Range Serological Survey of Crimean–Congo Hemorrhagic Fever among Hungarian Livestock
(1) Background: Crimean–Congo hemorrhagic fever (CCHF) is an emerging tick-borne disease endemic in Africa, Asia, the Middle East, and the Balkan and Mediterranean regions of Europe. Although no human CCHF cases have been reported, based on vector presence, serological evidence among small vertebrates, and the general human population, Hungary lies within high evidence consensus for potential CCHF introduction and future human infection. Thus, the aim of our pilot serosurvey was to assess CCHF seropositivity among cattle and sheep as indicator animals for virus circulation in the country. (2) Methods: In total, 1905 serum samples taken from free-range cattle and sheep in 2017 were tested for the presence of anti-CCHF virus IgG antibodies using commercial ELISA and commercial and in-house immunofluorescent assays. (3) Results: We found a total of eleven reactive samples (0.58%) from five administrative districts of Hungary comprising 8 cattle and 3 sheep. The most affected regions were the south–central and northwestern parts of the country. (4) Conclusions: Based on these results, more extended surveillance is advised, especially in the affected areas, and there should be greater awareness among clinicians and other high-risk populations of the emerging threat of CCHF in Hungary and Central Europe.
- 1 January 2022
- Published by Magyar Egeszsegugyi Szakdolgozoi Kamara in Nővér
- Vol. 35 (5) , 34-40
A majomhimlőjárvány hazai tanulságai
A majomhimlő egy több évtizede ismert, állatokról emberre terjedő fertőző megbetegedés, amit az Orthopoxvirusok közé tartozó majomhimlővírus okoz. Ugyanennek a vírusnemzetségnek a tagja a variola, a fekete himlő vírusa is. Az első emberi majomhimlős esetet 1970-ben írták le a Kongói Demokratikus Köztársaságban. A betegség járványosan Nyugat- és Közép-Afrikában terjed, és csak elvétve okozott megbetegedéseket Afrikán kívül. A majomhimlővírus egyik emberről a másikra sérülésekkel, testnedvekkel, légúti cseppfertőzéssel és szennyezett anyagokkal, például ágyneművel való szoros érintkezés útján is terjed. Újdonságnak számít a vírus európai jelenléte és terjedése. A betegség tünetei hasonlítanak a fekete himlőre, amelyről a WHO 1980-ban azt közölte, hogy eltűnt a Föld felszínéről. Az első, Afrikán kívüli majomhimlőjárványt 2003-ban regisztrálták az Amerikai Egyesült Államokban. 2022. május 7-e óta számos európai ország majomhimlő okozta megbetegedéseket jelentett a WHO felé, május 31-én pedig Magyarországon is azonosították a zoonosist. A WHO tájékoztatása alapján a legtöbb beteg saját bevallása szerint ’MSM’ (man who have sex with men) férfi. A majomhimlővírus- (monkeypox virus – MPXV-) járvány megelőzése a fertőzött beteg elkülönítésével, a higiéniai szabályok betartásával, megfelelő kézmosással, alkoholos fertőtlenítőszerekkel, valamint az egészségügyi ellátás során az egyéni védőeszközök megfelelő alkalmazásával történhet. Cikkünkben a napjainkban zajló majomhimlőjárvánnyal foglalkozunk és az alábbi témaköröket érintjük: epidemiológia, diagnosztika, klinikum, az infekciókontroll szabályai és a majomhimlő terjedésének jellemzői.
- 1 January 2022
- Published by Magyar Egeszsegugyi Szakdolgozoi Kamara in Nővér
- Vol. 35 (5) , 34-40
A majomhimlőjárvány hazai tanulságai
A majomhimlő egy több évtizede ismert, állatokról emberre terjedő fertőző megbetegedés, amit az Orthopoxvirusok közé tartozó majomhimlővírus okoz. Ugyanennek a vírusnemzetségnek a tagja a variola, a fekete himlő vírusa is. Az első emberi majomhimlős esetet 1970-ben írták le a Kongói Demokratikus Köztársaságban. A betegség járványosan Nyugat- és Közép-Afrikában terjed, és csak elvétve okozott megbetegedéseket Afrikán kívül. A majomhimlővírus egyik emberről a másikra sérülésekkel, testnedvekkel, légúti cseppfertőzéssel és szennyezett anyagokkal, például ágyneművel való szoros érintkezés útján is terjed. Újdonságnak számít a vírus európai jelenléte és terjedése. A betegség tünetei hasonlítanak a fekete himlőre, amelyről a WHO 1980-ban azt közölte, hogy eltűnt a Föld felszínéről. Az első, Afrikán kívüli majomhimlőjárványt 2003-ban regisztrálták az Amerikai Egyesült Államokban. 2022. május 7-e óta számos európai ország majomhimlő okozta megbetegedéseket jelentett a WHO felé, május 31-én pedig Magyarországon is azonosították a zoonosist. A WHO tájékoztatása alapján a legtöbb beteg saját bevallása szerint ’MSM’ (man who have sex with men) férfi. A majomhimlővírus- (monkeypox virus – MPXV-) járvány megelőzése a fertőzött beteg elkülönítésével, a higiéniai szabályok betartásával, megfelelő kézmosással, alkoholos fertőtlenítőszerekkel, valamint az egészségügyi ellátás során az egyéni védőeszközök megfelelő alkalmazásával történhet. Cikkünkben a napjainkban zajló majomhimlőjárvánnyal foglalkozunk és az alábbi témaköröket érintjük: epidemiológia, diagnosztika, klinikum, az infekciókontroll szabályai és a majomhimlő terjedésének jellemzői.